Automatic Pill Dispenser Market

Executive Summary

Automatic Pill Dispenser Market was valued at US $3.02 billion in 2021 and is projected to grow at 8.18% CAGR over the forecast period to reach US $4.84 billion by 2027. Automatic Pill Dispenser Market represented US $0.44 billion opportunity over 2019-2021 and estimated to create US $1.82 billion opportunity in 2027 over 2021.

Automatic Pill Dispenser from Consainsights analyses the Automatic Pill Dispenser Market in the Life Sciences industry over the forecast period to 2027.

Automatic Pill Dispenser research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Automatic Pill Dispenser segmentation includes Type, Indication, End-User and Geography.

Based on the Type, the Automatic Pill Dispenser analysis covers Centralized Automatic Dispenser, Decentralized Automatic Dispenser.

In Type segment, Centralized Automatic Dispenser segment has highest cagr growth of 7.24%.

Based on the Indication, the Automatic Pill Dispenser analysis covers Physical Disability, Neurodegenerative Disorders and Dementia, Others.

In Indication segment, Physical Disability segment has highest cagr growth of 7.24%.

Based on the End-User, the Automatic Pill Dispenser analysis covers Hospitals, Pharmacy, Home Healthcare.

In End-User segment, Hospitals segment has highest cagr growth of 7.24%.

Based on the region, the Automatic Pill Dispenser analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Becton Dickinson and Company, Capsa Healthcare, Cerner Corporation, Mckesson Corporation, Omnicell, ScriptPro LLC, Swisslog Healthcare, Talyst LLC, Yuyama Co Ltd, Koninklijke Philips N.V., Hero Health, Inc, Pharmacell Medications Systems Ltd, Medminder Systems, Inc and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Centralized Automatic Dispenser segment has the highest revenue of US $2.26 billion and is expected to grow at CAGR of 7.24% by 2027 Centralized Automatic Dispenser segment has highest cagr growth of 7.24%.

Centralized Automatic Dispenser

Centralized Automatic Dispenser segment was valued at US $1.93 billion in 2019 and is projected to grow at 7.24% CAGR over the forecast period to reach US $3.63 billion by 2027. Centralized Automatic Dispenser segment represented US $0.33 billion opportunity over 2019-2021 and estimated to create US $1.37 billion opportunity in 2027 over 2021.

Decentralized Automatic Dispenser

Decentralized Automatic Dispenser segment was valued at US $0.64 billion in 2019 and is projected to grow at 7.24% CAGR over the forecast period to reach US $1.21 billion by 2027. Decentralized Automatic Dispenser segment represented US $0.11 billion opportunity over 2019-2021 and estimated to create US $0.45 billion opportunity in 2027 over 2021.

Indication

Introduction

In 2021, Physical Disability segment has the highest revenue of US $1.55 billion and is expected to grow at CAGR of 7.24% by 2027 Physical Disability segment has highest cagr growth of 7.24%.

Physical Disability

Physical Disability segment was valued at US $1.33 billion in 2019 and is projected to grow at 7.24% CAGR over the forecast period to reach US $2.49 billion by 2027. Physical Disability segment represented US $0.23 billion opportunity over 2019-2021 and estimated to create US $0.94 billion opportunity in 2027 over 2021.

Neurodegenerative Disorders and Dementia

Neurodegenerative Disorders and Dementia segment was valued at US $0.90 billion in 2019 and is projected to grow at 7.24% CAGR over the forecast period to reach US $1.68 billion by 2027. Neurodegenerative Disorders and Dementia segment represented US $0.15 billion opportunity over 2019-2021 and estimated to create US $0.63 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $0.36 billion in 2019 and is projected to grow at 7.24% CAGR over the forecast period to reach US $0.67 billion by 2027. Others segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.25 billion opportunity in 2027 over 2021.

End-User

Introduction

In 2021, Hospitals segment has the highest revenue of US $1.47 billion and is expected to grow at CAGR of 7.24% by 2027 Hospitals segment has highest cagr growth of 7.24%.

Hospitals

Hospitals segment was valued at US $1.25 billion in 2019 and is projected to grow at 7.24% CAGR over the forecast period to reach US $2.35 billion by 2027. Hospitals segment represented US $0.21 billion opportunity over 2019-2021 and estimated to create US $0.89 billion opportunity in 2027 over 2021.

Pharmacy

Pharmacy segment was valued at US $0.71 billion in 2019 and is projected to grow at 7.24% CAGR over the forecast period to reach US $1.34 billion by 2027. Pharmacy segment represented US $0.12 billion opportunity over 2019-2021 and estimated to create US $0.50 billion opportunity in 2027 over 2021.

Home Healthcare

Home Healthcare segment was valued at US $0.61 billion in 2019 and is projected to grow at 7.24% CAGR over the forecast period to reach US $1.14 billion by 2027. Home Healthcare segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.43 billion opportunity in 2027 over 2021.